Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:56 PM
Ignite Modification Date:
2025-12-24 @ 12:56 PM
NCT ID:
NCT04618861
Eligibility Criteria:
For patients;
Inclusion Criteria:
* who presented to the Covid-19 outpatient polyclinic of the ED with pneumonia symptoms,
* whose CT imaging's were compatible with Covid-19 pneumonia in accordance with the RSNAEC criteria and whose PCR tests were positive,
* whose SARS-CoV-2 PCR tests were positive as a result of contact tracing,
* who presented to the ED for further examination.
* who gave their written consent to participate in the study.
* Giving written consent to participate in the study.
Exclusion Criteria:
* diagnosis of kidney or liver failure
* acute pulmonary embolism
* chronic inflammatory disease history (rheumatological disease, autoimmune disease),
* pregnancy
* presence of any cancer diagnosis
* chronic obstructive pulmonary disease
* asthma disease,
* history of cerebrovascular disease.
* the patients whose CT imagings were compatible with Covid-19 pneumonia but whose PCR tests were negative were also excluded from the study.
For control group Inclusion Criteria
* no known acute, subacute or chronic disease history
* not suffer from any infection in the last fortnight,
* not to be on a particular medication,
* Presenting to the ED with reasons other than infectious complaints
* Giving written consent to participate in the study.
Exclusion Criteria:
* diagnosis of kidney or liver failure
* acute pulmonary embolism
* chronic inflammatory disease history (rheumatological disease, autoimmune disease),
* pregnancy
* presence of any cancer diagnosis
* chronic obstructive pulmonary disease
* asthma disease,
* history of cerebrovascular disease.
Minimum Age:
18 Years
Study:
NCT04618861
Study Brief:
Protocol Section:
NCT04618861